340 related articles for article (PubMed ID: 35912267)
1. Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma.
Zelli V; Compagnoni C; Capelli R; Corrente A; Di Vito Nolfi M; Zazzeroni F; Alesse E; Tessitore A
Front Oncol; 2022; 12():940056. PubMed ID: 35912267
[TBL] [Abstract][Full Text] [Related]
2. The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications.
Pascut D; Pratama MY; Vo NVT; Masadah R; Tiribelli C
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235370
[TBL] [Abstract][Full Text] [Related]
3. The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma.
Wang W; Hao LP; Song H; Chu XY; Wang R
Front Oncol; 2022; 12():790916. PubMed ID: 35280805
[TBL] [Abstract][Full Text] [Related]
4. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
5. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.
Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL
World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996
[TBL] [Abstract][Full Text] [Related]
6. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
[TBL] [Abstract][Full Text] [Related]
7. Exosomal microRNAs in non-small cell lung cancer.
Duréndez-Sáez E; Torres-Martinez S; Calabuig-Fariñas S; Meri-Abad M; Ferrero-Gimeno M; Camps C
Transl Cancer Res; 2021 Jun; 10(6):3128-3139. PubMed ID: 35116621
[TBL] [Abstract][Full Text] [Related]
8. The utility of serum exosomal microRNAs in hepatocellular carcinoma.
Jun L; Yang G; Zhisu L
Biomed Pharmacother; 2019 Mar; 111():1221-1227. PubMed ID: 30841435
[TBL] [Abstract][Full Text] [Related]
9. Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review).
Yang S; Wang J; Wang S; Zhou A; Zhao G; Li P
Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35674180
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses.
Li S; Yao J; Xie M; Liu Y; Zheng M
J Hematol Oncol; 2018 Apr; 11(1):54. PubMed ID: 29642941
[TBL] [Abstract][Full Text] [Related]
11. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
[TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y
RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588
[TBL] [Abstract][Full Text] [Related]
13. Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma.
Chen X; Chi H; Zhao X; Pan R; Wei Y; Han Y
J Oncol; 2022; 2022():2521025. PubMed ID: 35126514
[TBL] [Abstract][Full Text] [Related]
14. The Role of MicroRNAs in Hepatocellular Carcinoma.
Xu X; Tao Y; Shan L; Chen R; Jiang H; Qian Z; Cai F; Ma L; Yu Y
J Cancer; 2018; 9(19):3557-3569. PubMed ID: 30310513
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma.
Wei XC; Xia YR; Zhou P; Xue X; Ding S; Liu LJ; Zhu F
World J Gastroenterol; 2021 Dec; 27(48):8302-8322. PubMed ID: 35068871
[TBL] [Abstract][Full Text] [Related]
16. Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance.
Santos P; Almeida F
Cells; 2020 Jun; 9(6):. PubMed ID: 32545155
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
Salehi M; Sharifi M
J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
[TBL] [Abstract][Full Text] [Related]
18. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
[TBL] [Abstract][Full Text] [Related]
19. The role of exosomes and miRNAs in drug-resistance of cancer cells.
Bach DH; Hong JY; Park HJ; Lee SK
Int J Cancer; 2017 Jul; 141(2):220-230. PubMed ID: 28240776
[TBL] [Abstract][Full Text] [Related]
20. Advances in Exosomal microRNAs and Proteins in Ovarian Cancer Diagnosis, Prognosis, and Treatment.
Qin T; Chen F; Zhu J; Ding Y; Zhang Q
Curr Mol Med; 2023; 23(6):509-520. PubMed ID: 35770407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
